idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
When the Siegert group succeeded in rejuvenating mice brains in 2021, they already suspected the method’s non-invasive and non-pharmaceutical potential to treat mental health disorders. Through the Institute’s technology transfer program, xista innovation, they launched a MedTech company called Syntropic Medical. Now, together with CEO Mark Caffrey and CTO Jack O’Keeffe, they secured seven-figure funding from xista’s venture fund and the Austria Wirtschaftsservice (AWS).
Syntropic’s spectacle-like brain stimulation device is based on a startling discovery: flickering light can help neurological treatment. Because the method can be applied to living organisms without surgery and does not require pharmaceuticals, lead researchers Alessandro Venturino and Sandra Siegert of the Institute of Science and Technology Austria (ISTA) immediately recognized its high therapeutic potential. Together with CEO Mark Caffrey and CTO Jack O'Keeffe, they founded the start-up Syntropic Medical through the Institute's innovation program xista innovation. Prototypes are currently being tested. The finished product is intended to be a therapy option that healthcare professionals can offer to their patients with mental health disorders.
CEO Mark Caffrey: “Approximately 70% of patients taking pharmaceutical antidepressants do not achieve remission and up to 25% stop taking them due to severe side effects. Unfortunately, these numbers are not good enough. It is therefore crucial that we begin to develop entirely new ways to treat these disorders. This is why the discoveries of Dr. Venturino and Prof. Siegert are so exciting, as they open up the potential for a completely new treatment modality that is free of side effects and simple for patients to use.”
The Secret of Syntropic Medical
Syntropic Medical is a medical device company based in Austria that is developing new technologies to enhance the brain's neuroplasticity. This means that the device allows the brain to more flexibly form new connections by softening the brain's stabilizing structures—the perineuronal nets. As a result, the brain temporarily returns to a state otherwise known from early developmental stages, such as childhood. By re-establishing plasticity, one could potentially alter detrimental structures more easily. This non-invasive therapy has the potential to treat major depressive disorder (MDD) and other neuropsychiatric disorders. It improves cognition and provides new options for patients who have not responded to traditional therapies.
“By developing a neuromodulation-based approach for mental health disorders, Syntropic Medical is addressing a market with a pressing need and significant potential,” adds Florian Resch, Managing Partner at xista science ventures. “We look forward to working with this ambitious team to commercialize the promising and innovative discoveries made in the Siegert lab at ISTA.”
xista science ventures – a venture fund from ISTA for DeepTech across Europe
xista science ventures is an Austrian venture fund that invests in early-stage life science and DeepTech startups across Europe. It is embedded in the xista innovation ecosystem, which was founded by the Institute of Science and Technology Austria (ISTA) to transfer knowledge from basic research to companies that generate returns for society. Combining the scientific and investor perspectives, xista science ventures is an active partner to its portfolio companies in the fields of BioTech, MedTech, material science, and software. Its goal is to support founders in the realization and scaling of scientific enterprises.
The venture fund is supported by InnovFin Equity, with financial support from the European Union under the Horizon 2020 Financial Instruments, and the European Fund for Strategic Investments (EFSI), established under the Investment Plan for Europe. The purpose of the EFSI is to support the financing and implementation of productive investments in the European Union and to ensure better access to finance.
***
About ISTA
The Institute of Science and Technology Austria (ISTA) is a PhD-granting research institution located in Klosterneuburg, 18 km from the center of Vienna, Austria. ISTA employs professors on a tenure-track model, post-doctoral researchers and PhD students. The Graduate School of ISTA offers fully funded PhD positions to highly qualified candidates with a Bachelor’s or Master’s degree in biology, mathematics, computer science, physics, chemistry, and related areas. While dedicated to the principle of curiosity-driven research, ISTA aims to deliver scientific findings to society through technological transfer and science education. President of the Institute is Martin Hetzer, a renowned molecular biologist and former Senior Vice President at The Salk Institute for Biological Studies in California, USA.
www.ista.ac.at
Mark Caffrey
CEO Syntropic Medical
mark@syntropicmedical.com
+353 87 164 8044
https://www.syntropicmedical.com/ --- Syntropic Medical GmbH
https://xista.io/ --- xista innovations, the technology transfer ecosystem of ISTA.
https://ist.ac.at/de/news/wie-man-ein-gehirn-verjuengt/ --- Original research article from 2021.
https://ista.ac.at/de/forschung/siegert-gruppe/ --- The Siegert group at ISTA.
Neuroscientist Alessandro Venturino showcasing Syntropic’s prototype.
Syntropic Medical GmbH
Syntropic Medical GmbH
Syntropic Medical CEO Mark Caffrey.
Mark Caffrey
Mark Caffrey
The goggle-like device, here a rendering of the product, temporarily returns the brain to a state of high plasticity, usually observed only with children.
Merkmale dieser Pressemitteilung:
Journalisten, Wirtschaftsvertreter
Biologie, Medizin, Psychologie
überregional
Forschungs- / Wissenstransfer, Forschungsergebnisse
Englisch
Neuroscientist Alessandro Venturino showcasing Syntropic’s prototype.
Syntropic Medical GmbH
Syntropic Medical GmbH
Syntropic Medical CEO Mark Caffrey.
Mark Caffrey
Mark Caffrey
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
